Lupin gets tentative USFDA nod for empagliflozin and metformin hydrochloride ER tablets
They are indicated as an adjunct to diet and exercise, to improve glycemic control in adults with type 2 diabetes mellitus
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
metformin hydrochloride
Sun Pharma recalls metformin due to high NDMA levels
NDMA is classified as a probable human carcinogen based on results from laboratory tests
Alembic Pharmaceuticals receives US FDA’s tentative approval for Empagliflozin and Metformin…
The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Synjardy Tablets of…
Lupin recalls diabetes treatment drug in US
The company said that it is voluntarily recalling its Metformin Hydrochloride extended-release tablets USP, 500 mg and 1000 mg…
Indian pharma firms recall medications from US market
Lupin and Marksans Pharma recall diabetes drugs while Alembic and Aurbindo recall medicines that treat mental disorders
Glenmark Pharma gets USFDA nod for diabetes management drug
The company's current portfolio consists of 164 products authorised for distribution in the US marketplace and 44 abbreviated new…